These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30499028)
1. The association between polypharmacy and late life deficits in cognitive, physical and emotional capability: a cohort study. Khezrian M; McNeil CJ; Myint PK; Murray AD Int J Clin Pharm; 2019 Feb; 41(1):251-257. PubMed ID: 30499028 [TBL] [Abstract][Full Text] [Related]
2. Association of Polypharmacy With Mild Cognitive Impairment and Cognitive Ability: A Nationwide Survey in Taiwan. Cheng CM; Chang WH; Chiu YC; Sun Y; Lee HJ; Tang LY; Wang PN; Chiu MJ; Yang CH; Tsai SJ; Tsai CF J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256550 [TBL] [Abstract][Full Text] [Related]
3. Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community. Niikawa H; Okamura T; Ito K; Ura C; Miyamae F; Sakuma N; Ijuin M; Inagaki H; Sugiyama M; Awata S Geriatr Gerontol Int; 2017 Sep; 17(9):1286-1293. PubMed ID: 27628036 [TBL] [Abstract][Full Text] [Related]
4. Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle. Silay K; Yalcin A; Akinci S; Gursoy FG; Sener Dede D Wien Klin Wochenschr; 2017 Nov; 129(21-22):799-804. PubMed ID: 28864869 [TBL] [Abstract][Full Text] [Related]
5. Late-life deficits in cognitive, physical and emotional functions, childhood intelligence and occupational profile: a life-course examination of the Aberdeen 1936 Birth Cohort (ABC1936). Chapko D; Staff RT; McNeil CJ; Whalley LJ; Black C; Murray AD Age Ageing; 2016 Jul; 45(4):486-93. PubMed ID: 27076527 [TBL] [Abstract][Full Text] [Related]
6. Polypharmacy and Cognition Function Among Rural Adults. Rasu RS; Shrestha N; Karpes Matusevich AR; Zalmai R; Large S; Johnson L; O'Bryant SE J Alzheimers Dis; 2021; 82(2):607-619. PubMed ID: 34057144 [TBL] [Abstract][Full Text] [Related]
7. Motoric Cognitive Risk Syndrome in Polypharmacy. George CJ; Verghese J J Am Geriatr Soc; 2020 May; 68(5):1072-1077. PubMed ID: 32092166 [TBL] [Abstract][Full Text] [Related]
8. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan. Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193 [TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment is independently associated with definitive and possible sarcopenia in hospitalized older adults: The prevalence and impact of comorbidities. Maeda K; Akagi J Geriatr Gerontol Int; 2017 Jul; 17(7):1048-1056. PubMed ID: 27273820 [TBL] [Abstract][Full Text] [Related]
10. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia. Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908 [TBL] [Abstract][Full Text] [Related]
11. The prevalence and impact of undiagnosed cognitive impairment in older vascular surgical patients. Partridge JS; Dhesi JK; Cross JD; Lo JW; Taylor PR; Bell R; Martin FC; Harari D J Vasc Surg; 2014 Oct; 60(4):1002-11.e3. PubMed ID: 25017513 [TBL] [Abstract][Full Text] [Related]
12. Association of polypharmacy with cognitive impairment in older trauma patients: a cross-sectional study. de Godoi Rezende Costa Molino C; Rübel L; Mantegazza N; Bischoff-Ferrari HA; Freystaetter G Eur J Hosp Pharm; 2024 Aug; 31(5):428-433. PubMed ID: 36882299 [TBL] [Abstract][Full Text] [Related]
14. Comorbid Mild Cognitive Impairment and Depressive Symptoms Predict Future Dementia in Community Older Adults: A 24-Month Follow-Up Longitudinal Study. Makizako H; Shimada H; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Makino K; Suzuki T J Alzheimers Dis; 2016 Oct; 54(4):1473-1482. PubMed ID: 27589518 [TBL] [Abstract][Full Text] [Related]
15. Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis. Swami S; Cohen RA; Kairalla JA; Manini TM Drugs Aging; 2016 Nov; 33(11):809-818. PubMed ID: 27638818 [TBL] [Abstract][Full Text] [Related]
16. Association of polypharmacy and motoric cognitive risk syndrome in older adults: A 4-year longitudinal study in China. Liang H; Fang Y Arch Gerontol Geriatr; 2023 Mar; 106():104896. PubMed ID: 36508849 [TBL] [Abstract][Full Text] [Related]
17. Association between polypharmacy and cognitive impairment in older adults: A systematic review and meta-analysis. Yu X; Qian Y; Zhang Y; Chen Y; Wang M Geriatr Nurs; 2024; 59():330-337. PubMed ID: 39111065 [TBL] [Abstract][Full Text] [Related]
18. Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study. Rawle MJ; Cooper R; Kuh D; Richards M J Am Geriatr Soc; 2018 May; 66(5):916-923. PubMed ID: 29574684 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Pain on Major Cognitive Impairment in Older Adults. van der Leeuw G; Ayers E; Leveille SG; Blankenstein AH; van der Horst HE; Verghese J J Pain; 2018 Dec; 19(12):1435-1444. PubMed ID: 30004021 [TBL] [Abstract][Full Text] [Related]
20. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication. Schöttker B; Saum KU; Muhlack DC; Hoppe LK; Holleczek B; Brenner H Eur J Clin Pharmacol; 2017 Aug; 73(8):1041-1048. PubMed ID: 28540438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]